triazoles has been researched along with lansoprazole in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Higaki, T; Itokawa, T; Kami, M; Komatsu, T; Miura, Y; Murashige, N; Murata, K; Takei, N; Tsubokura, M | 1 |
| Fujieda, A; Iwamoto, T; Katayama, N; Monma, F; Nakatani, K; Okuda, M | 1 |
| Gao, Y; Hao, S; Sun, J; Sun, X; Tian, X; Zhang, Z | 1 |
| Gottschalk, M; Griffin, KJ; Kyllo, JH; Rabinovitch, A; Thompson, PA | 1 |
| Becker, DP; Caulfield, TR; Durvasula, R; Goicoechea, S; Gupta, Y; Kempaiah, P; Mathur, R; Romero, JG | 1 |
1 trial(s) available for triazoles and lansoprazole
| Article | Year |
|---|---|
Combination therapy with sitagliptin and lansoprazole in patients with recent-onset type 1 diabetes (REPAIR-T1D): 12-month results of a multicentre, randomised, placebo-controlled, phase 2 trial.
Topics: Adolescent; Adult; Child; Diabetes Mellitus, Type 1; Dipeptidyl-Peptidase IV Inhibitors; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypoglycemic Agents; Insulin-Secreting Cells; Lansoprazole; Male; Pyrazines; Sitagliptin Phosphate; Treatment Outcome; Triazoles; United States | 2014 |
4 other study(ies) available for triazoles and lansoprazole
| Article | Year |
|---|---|
Fatal dysrhythmia following initiation of lansoprazole during a long-term course of voriconazole.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Antifungal Agents; Aspergillosis; Drug Interactions; Fatal Outcome; Humans; Lansoprazole; Male; Pyrimidines; Tachycardia, Ventricular; Triazoles; Voriconazole | 2011 |
Hepatic drug interaction between tacrolimus and lansoprazole in a bone marrow transplant patient receiving voriconazole and harboring CYP2C19 and CYP3A5 heterozygous mutations.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Antifungal Agents; Aryl Hydrocarbon Hydroxylases; Bone Marrow Transplantation; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP3A; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Humans; Immunosuppressive Agents; Infusions, Intravenous; Lansoprazole; Liver; Male; Mutation; Pyrimidines; Tacrolimus; Triazoles; Voriconazole | 2011 |
Lansoprazole enhances the antidiabetic effect of sitagliptin in mice with diet-induced obesity and healthy human subjects.
Topics: Adult; Animals; Area Under Curve; Blood Glucose; C-Peptide; Diet; Drug Synergism; Drug Therapy, Combination; Glucose; Glucose Tolerance Test; Humans; Hypoglycemic Agents; Insulin; Lansoprazole; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Obesity; Pyrazines; Sitagliptin Phosphate; Triazoles | 2014 |
Repurposing Lansoprazole and Posaconazole to treat leishmaniasis: Integration of in vitro testing, pharmacological corroboration, and mechanisms of action.
Topics: Antiprotozoal Agents; Drug Repositioning; Humans; In Vitro Techniques; Lansoprazole; Leishmania; Leishmaniasis; Triazoles | 2022 |